Financials
Insiders
Investors activity for: INBX, INBX
SEC Reports

Inhibrx Biosciences, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol: INBX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 11025 N. Torrey Pines Road, Suite 140, La Jolla, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+223K	100%	$14.20	+$3.16M
Sells	0
Net	+4	+223K	100%		+$3.16M

Inhibrx Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jon Faiz Kayyem	Director	$14.1M			Jun 24, 2024
Mark Lappe	Chief Executive Officer, Director	$13.4M	+$1.79M	+15.3%	Sep 6, 2024
Brendan P. Eckelman	Chief Scientific Officer	$6.13M			May 29, 2024
Douglas Forsyth	Director	$3.16M	+$1.04M	+48.9%	Aug 22, 2024
Viking Global Investors Lp	10%+ Owner	$1.65M			May 29, 2024
Kristiina Vuori	Director	$208K	+$200K	+2613%	Sep 10, 2024
Kimberly Manhard	Director	$140K	+$140K		Aug 28, 2024
Kelly Deck	Chief Financial Officer				May 30, 2024
Inhibrx, Inc.	10%+ Owner				May 29, 2024

Recent Insider Transactions by Companies or Individuals for Inhibrx Biosciences, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.